Although we presume that these results are mainly due to reduced ARP2/3-dependent cancer cell invasion14, decreasing the expression of anti-angiogenic genes that are regulated by RUNX1 (e.g., Ang1 and IGFBP3) may have played a role as well. The gene discussed is ANGPT1; the disease is cancer.